Identification of broadly reactive DR restricted epitopes
A primary and auxiliary technology, applied in the direction of medical preparations containing active ingredients, receptors/cell surface antigens/cell surface determinants, specific peptides, etc., can solve problems such as laborious alleles
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0061] Materials and methods
[0062] cell. The following Epstein-Barr virus (EBV)-transformed homozygous cell lines were used as a source of human HLA class II molecules: LG2[DRB1c0101(DR1)1; GM3107[DRB50101(DR2w2a)]; MAT(DRB10301(DR3)1; PREISS[DRB 10401 (DR4w4)1; BIN40[DRB10404(DR4w14)1; SWEIG[DRB11101(DR5w11)]; PIOUT[DRB10701(DR7)](a); KT3[DRB0405(DR4w15)]; Herluf[DRB11201(DR5w12)]; HO301[ DRB11302(DR6w19)]; OLL[DRB10802(DR8w2)]; and HTC9074[DRB10901(DR9), generously provided by Dr. Paul Harris, Columbia University]. In some cases, transfected fibroblasts were employed: L466.1[ DRB11501(DR2w2b)]; TR81.19[DRB30101(DR52a)]; and L257.6[DRB40101(DRw53)].(Valli et al., J.Clin.Invest.91:616(1993)). Cells were cultured in They were maintained in vitro in RPMI 1640 medium supplemented with 2 mM L-glutamine [GIBCO, Grand Island, NY], 50 μM 2-ME, and 10% heat-inactivated FCS [Irvine Scientific, Santa Ana, CA]. Cells were also supplemented with 100 μg / ml streptomycin and 100 U / ml p...
PUM
Property | Measurement | Unit |
---|---|---|
affinity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com